Skip to main content

Tower Research Capital LLC (TRC)

Position in ACRV — Acrivon Therapeutics, Inc.

CIK 1533421 NEW YORK, NY

Position in ACRV

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$2,985
-$3,306 QoQ
Shares Held
1,677
-62.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 46 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACRV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,479,230 across 466 Biotechnology names. ACRV ranks #409 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACRV

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,985 1,677
2026-03-31 $6,291 4,526
2025-09-30 $15,812 8,736
2025-06-30 $10,524 8,844
2025-03-31 $6,272 3,090
2024-12-31 $10,631 1,766
2024-09-30 $33,285 4,755
2024-06-30 $21,918 3,779
2024-03-31 $5,841 817
2023-12-31 $9,927 2,018
2023-09-30 $11,997 1,255
2023-06-30 $9,486 732
2023-03-31 $13,857 1,092
2022-12-31 $1,831 159